Diploma PLC : Upward target on the trendline
Entry price | Target | Stop-loss | Potential |
---|
GBX 650 |
GBX 0 |
GBX 619 |
-100% |
---|
The GBp 608 support area, currently tested, might facilitate a technical rebound. The company’s fundamentals could validate this scenario.
However, analysts have revised slightly downward their earnings forecasts.
After several weeks of horizontal fluctuations within the mid-term range GBp 608 / 764, the stock is coming back close to the lower limit of the range.
Moving averages are almost flat and technical indicators illustrate the oversold situation. The GBp 632 area, which has just been tested, could cause a positive reaction for the coming trading sessions and allow a technical rebound towards the GBp 706 short-term resistance and then to the trend-line in near the GBp 740.
So as to make the most of a potential technical rebound of Diploma, it seems opportune to open a long trade at current prices. A confirmation of this pattern would enable the security to reach the trendline in the GBp 740 area. Investors should not insist under GBp 632 and are better of placing a stop-loss order under this threshold.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.